Patent · US Active

Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof

US9815883B2 · kind B2 · utility

2Cited by

7References

4Claims

0Family size

Assignees

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
Universite de Lorraine · FR

Inventors

Sebastien Gibot · Vandœuvre-lès-Nancy, FR
Marc Derive · Montataire, FR

Key dates

Filing date	Apr 29, 2015
Grant date	Nov 14, 2017
Priority date	—
Expiry date	Apr 29, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to polypeptides fragments derived from the protein TLT-1 and their uses for the treatment of inflammatory conditions and more particularly for the treatment of sepsis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.